Posterbeiträge

 

 

Weitere Details zu den Postern und einen passenden Download finden Sie in den Bereichen Posterbeiträge der einzelnen Jahre.

 

2020

 

  • Comparison of bleeding rate and factor consumption between extended and short half-life factor VIII in real life according to electronic documentation smart medication

(64th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Five-year follow-up in haemophilia care comparing real life data from electronic documentation smart medication

(64th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Pain and treatment related to joint bleeds – comparison of data between 2017 and 2018 according to electronic diary smart medication

(64th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Electronic diary smart medication for patients with haemophilia in the context of the Digital Care Act (Digitale-Versorgung-Gesetz, DVG)

(64th Annual Meeting of the Society of Thrombosis and Haemostasis Research) 

  • Telehealth in Haemophilia Treatment - Use and Recommendation Intentions of Patients and Physicians

(64th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

 

 

  • Comparison of electronic documentation with smart medication between 2014 and 2017

(63th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • smart medication ITP – feasibility of online surveillance in patients with immunthrombocytopenia

(63th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Impact of GDPR (DSGVO) on smart medication electronic patient diary

(63th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • smart medication – a pilot study for investigating the feasibility of speech recognition of natural language to access electronic patient diary

(63th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

 

 

  • An advanced reporting module within the smart medication platform simplifies mandatory reporting into the German Hemophilia Registry (DHR)

(62th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Ensuring information security for the electronic patient diary smart medication by applying an Information Security Management System(ISMS) based on the international standards ISO/IEC 27001 and ISO/IEC 27799

(62th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Prophylactic vs. on demand treatment in haemophilia patients - real life data according to electronic diary smart medication

(62th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Bleeding vs. Factor VIII/IX consumption - comparison of annual real-life results between 2014 and 2016 according to electronic diary smart medication

(62th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

 

 

  • Monitoring of perioperative factor VIII treatment in a remote hospital by electronic diary smart medication

(61th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Annual Bleeding vs. Factor VIII/IX consumption – comparison of result in 2014 and 2015 according to electronic diary smart medication

(61th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Comparison of data security of the electronic patient diary smart medication with manual documentation in a paper diary

(61th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

 

 

  • Annual Bleeding vs. Factor VIII/IX consumption – what is the optimal dose according to electronic diary smart medication

(60th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Prophylactic vs. on demand treatment in haemophilia patients – real life data according to electronic diary smart medication

(60th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

  • Daytime of prophylaxis and bleeding frequency: real life data from the electronic diary smart medication

(60th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

 

 

  • The electronic diary smart medication allows a rapid and comprehensive overview of haemophilia home treatment

(WFH 2014 World Congress)

  • Elektronisches Substitutionstagebuch ermöglicht einen unmittelbaren und umfassenden Überblick bei der Heimselbstbehandlung in der Hämophilie

(2. Bayerischer Tag der Telemedizin)

  • smart medication Allows a Rapid and Comprehensive Overview of Haemophilia Home Treatment 

(58. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH))

 

 

  • High acceptance of smart medication as telemetric tool for surveillance and treatmentin haemophilia home care

(57. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH))

 

 

  • smart medication - a new telemetric smartphone application for monitoring and evaluation of hemophilia home treatment

(WFH 2012 World Congress, July 8-12, Paris, France)

  • Improved surveillance of haemophilia home treatment using a telemetric smartphone application

(56th Annual Meeting of the Society of Thrombosis and Haemostasis Research)

 

 

  • Implementation of a telemetric smartphone application for improved surveillance of hemophilia home treatment

(XXIII Congress of the International Society on Thrombosis and Haemostasis & 57th Annual Meeting of the Scientific and Standardization Committee of the ISTH)